Search hospitals > Ohio > Canton
Novartis Investigative Site
Claim this profileCanton, Ohio 44718
Global Leader in Breast Cancer
Conducts research for Sclerosis
Conducts research for Multiple Sclerosis
Conducts research for Heart Failure
Conducts research for Arthritis
117 reported clinical trials
2 medical researchers
Summary
Novartis Investigative Site is a medical facility located in Canton, Ohio. This center is recognized for care of Breast Cancer, Sclerosis, Multiple Sclerosis, Heart Failure, Arthritis and other specialties. Novartis Investigative Site is involved with conducting 117 clinical trials across 124 conditions. There are 2 research doctors associated with this hospital, such as Brendan Duffy, MD and Richard DRACHTMAN.Area of expertise
1Breast Cancer
Global LeaderER positive
PR positive
HER2 negative
2Sclerosis
Top PIs
Brendan Duffy, MDAultman Hospital7 years of reported clinical research
Studies Coronary Artery Disease
Studies Myocardial Ischemia
3 reported clinical trials
4 drugs studied
Richard DRACHTMANUMDNJ6 years of reported clinical research
Studies Sickle Cell Disease
Studies Sickle Cell Anemia
1 reported clinical trial
1 drug studied
Clinical Trials running at Novartis Investigative Site
Multiple Sclerosis
Sclerosis
Spinal Muscular Atrophy
Coronary Artery Disease
Cardiovascular Disease
Acute Coronary Syndrome
Syndrome
Muscular Atrophy
Atrophy
Myocardial Ischemia
Ofatumumab
for Multiple Sclerosis
This trial will test if patients with a specific type of multiple sclerosis benefit from switching to a new medication. The medication aims to reduce harmful cells in the nervous system, potentially preventing future issues. It has been approved in several countries for treating this condition.
Recruiting3 awards Phase 410 criteria
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares remibrutinib and teriflunomide in patients with relapsing multiple sclerosis. It aims to find out which medication is more effective and safer. Both drugs work by controlling the immune system to reduce relapses. Teriflunomide is an approved treatment for adults with this condition.
Recruiting2 awards Phase 3
Fingolimod
for Pediatric Multiple Sclerosis
To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS)
Recruiting1 award Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in Canton, Ohio. This center is recognized for care of Breast Cancer, Sclerosis, Multiple Sclerosis, Heart Failure, Arthritis and other specialties. Novartis Investigative Site is involved with conducting 117 clinical trials across 124 conditions. There are 2 research doctors associated with this hospital, such as Brendan Duffy, MD and Richard DRACHTMAN.